CFA
EVH icon

Cahill Financial Advisors’s Evolent Health EVH Stock Holding History

Cahill Financial Advisors’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-282
Closed -$9K – 398
2021
Q3 		$9K Buy
+282
New +$6.77K ﹤0.01% 567

Other funds holding EVH

EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Cahill Financial Advisors's EVH Position: Q4 2021 in Review

Cahill Financial Advisors sold out of Evolent Health (EVH) in Q4 2021, closing a stake of 282 shares — an estimated $9K sold.

Cahill Financial Advisors first reported a position in EVH in Q3 2021 and held it in 1 quarter. The position peaked at $9K in Q3 2021. 207 funds tracked by Wall St. Rank hold EVH as of Q4 2021.

  • Cahill Financial Advisors reported no remaining Evolent Health position as of Q4 2021 after selling out during the quarter.
  • Cahill Financial Advisors sold 282 Evolent Health shares in Q4 2021, an estimated $9K.
  • Cahill Financial Advisors first reported a position in Evolent Health in Q3 2021 and held it in 1 quarter.
  • Cahill Financial Advisors's Evolent Health position peaked at $9K in Q3 2021.
  • 207 funds tracked by Wall St. Rank held Evolent Health as of Q4 2021.

Based on Cahill Financial Advisors's 13F filing for Q4 2021, filed 11 Feb 2022.